Clearside Biomedical: Q1 Earnings Insights


Clearside Biomedical CLSD reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


Clearside Biomedical missed estimated earnings by 62.5%, reporting an EPS of $-0.13 versus an estimate of $-0.08.

Revenue was up $313.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 42.59% increase in the share price the next day.

Here's a look at Clearside Biomedical's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.16 -0.08 -0.12 -0.10
EPS Actual 0.31 -0.08 -0.11 -0.13
Revenue Estimate 17.77M 2.58M 690.00K 2.12M
Revenue Actual 25.69M 3.07M 780.00K 34.00K

To track all earnings releases for Clearside Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings




Posted In: EarningsBZI-Recaps